foxo4-dri senolytic 2024 study

foxo4-dri senolytic 2024 study Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis Targeting Cellular Senescence in Aging

Name: foxo4-dri senolytic 2024 study Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis Targeting Cellular Senescence in Aging
Brand: crisbcreativa.com
SKU: 83059870633
Price: 29.67 USD
Availability: InStock
Rating: 4.7857 (16 reviews)

Targeting Cellular Senescence in Aging and Age Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies FOXO4 an overview ScienceDirect Topics foxo4 dri peptide senolytic mouse study 2023 2024 Molecular modelling of the FOXO4 TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4 DRI Peptide for Cellular Frontiers Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications

SKU: 83059870633 · From crisbcreativa.com

4.8

USD29.67 USD52.67

Pay in 4 interest-free payments of $7.42 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 18 - Sep 23

Description

Stable Gastric Pentadecapeptide BPC 157 and Wound Healing All AbMole products are for research use only, cannot be used for human consumption or veterinary use